Inventor · disambiguated record
Francis Joseph Carr
Also filed as: CARR FRANCIS · CARR FRANCIS J · CARR FRANCIS JOSEPH · CARR II FRANCIS J
93 granted patents·45 pending applications·2,028 citations·filing 1985–2023
99Inventor score
Files withMERCK PATENT GMBH18CELLDEX THERAPEUTICS INC6LUDWIG INST CANCER RES6BIOVATION LTD5AGEN BIOMEDICAL LTD4
Top patents by PatentIndex Score
138 records- 0198US9677055B2Modified forms of Pseudomonas exotoxin AINTREXON CORP·Filed 2016·Granted Jun 13, 2017·23 cites·23 claims
- 0298US9102727B2Human anti-PD-1 antibodies and uses thereforDANA FARBER CANCER INST INC·Filed 2013·Granted Aug 11, 2015·181 cites·21 claims
- 0397US8552154B2Anti-PD-L1 antibodies and uses thereforFREEMAN GORDON J·Filed 2009·Granted Oct 8, 2013·460 cites·12 claims
- 0496US10011656B2Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses thereforDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 3, 2018·24 cites·11 claims
- 0596US7514078B2Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodiesCORNELL RES FOUNDATION INC·Filed 2003·Granted Apr 7, 2009·75 cites·140 claims
- 0695US10781267B2Methods of treating by administering anti-kit antibodiesCELLDEX THERAPEUTICS INC·Filed 2018·Granted Sep 22, 2020·7 cites·22 claims
- 0795US8076459B2Multispecfic deimmunized CD3-bindersHOFMEISTER ROBERT·Filed 2004·Granted Dec 13, 2011·97 cites·31 claims
- 0895US7045605B2Modified antibodies to prostate-specific membrane antigen and uses thereofCORNELL RES FOUNDATION INC·Filed 2002·Granted May 16, 2006·80 cites·142 claims
- 0994US9102736B2Multispecific deimmunized CD3-bindersHOFMEISTER ROBERT·Filed 2011·Granted Aug 11, 2015·37 cites·37 claims
- 1094US7125689B2Method for rendering streptokinase less immunogenic to a humanBIOVATION LTD·Filed 2002·Granted Oct 24, 2006·67 cites·1 claims
- 1193US8932586B2Modified forms of Pseudomonas exotoxin AJONES TIMOTHY DAVID·Filed 2012·Granted Jan 13, 2015·11 cites·15 claims
- 1293US8337844B2CD20-binding polypeptide compositions for treating autoimmune diseaseCARR FRANCIS JOSEPH·Filed 2012·Granted Dec 25, 2012·25 cites·19 claims
- 1393US6310185B1Recombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1994·Granted Oct 30, 2001·112 cites·6 claims
- 1492US10202457B2Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and strokeUNIV BOSTON·Filed 2016·Granted Feb 12, 2019·8 cites·8 claims
- 1592US10184007B2Methods of treating a kit-associated cancer by administering anti-kit antibodiesCELLDEX THERAPEUTICS INC·Filed 2017·Granted Jan 22, 2019·9 cites·20 claims
- 1692US9605081B2Polynucleotides encoding anti-kit antibodiesKOLLTAN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·13 cites·8 claims
- 1791US9181343B2Antibody specific for CD22 and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2013·Granted Nov 10, 2015·13 cites·30 claims
- 1891US7189830B2Anti-KSA/IL-2 fusion proteins with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Mar 13, 2007·29 cites·1 claims
- 1991US7132511B2Modified anti-EGFR antibodies with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Nov 7, 2006·46 cites·3 claims
- 2090US10370448B2Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses thereforDANA FARBER CANCER INST INC·Filed 2018·Granted Aug 6, 2019·5 cites·18 claims
- 2190US9714290B2Humanised anti CTLA-4 antibodiesJONES TIMOTHY DAVID·Filed 2012·Granted Jul 25, 2017·18 cites·19 claims
- 2290US9447387B2Modified forms of pseudomonas exotoxin AINTREXON CORP·Filed 2015·Granted Sep 20, 2016·3 cites·22 claims
- 2390US9334332B2Anti-kit antibodiesKOLLTAN PHARMACEUTICALS INC·Filed 2013·Granted May 10, 2016·14 cites·58 claims
- 2490US6391302B1Method for treating cancers which present antigen FB5 with humanized antibodiesLUDWIG INST CANCER RES·Filed 2000·Granted May 21, 2002·18 cites·14 claims
- 2589US8147832B2CD20-binding polypeptide compositions and methodsCARR FRANCIS JOSEPH·Filed 2004·Granted Apr 3, 2012·33 cites·19 claims
- 2689US7430476B2Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Sep 30, 2008·24 cites·5 claims
- 2789US5952484ARecombinant human anti-LK26 antibodiesSLOAN KETTERING CANCER CENTER·Filed 1996·Granted Sep 14, 1999·84 cites·6 claims
- 2889US5646253ARecombinant human anti-LK26 antibodiesSLOAN KETTERING INST CANCER·Filed 1994·Granted Jul 8, 1997·58 cites·2 claims
- 2988US11866509B2Humanized antibodies against CEACAM1FAMEWAVE LTD·Filed 2020·Granted Jan 9, 2024·2 cites·18 claims
- 3088US7339031B2Modified bouganin proteins, cytotoxins and methods and uses thereofMERCK PATENT GMBH·Filed 2005·Granted Mar 4, 2008·11 cites·19 claims
- 3188US6348195B1Method for treating cancersSLOAN KETTERING INST CANCER·Filed 2000·Granted Feb 19, 2002·25 cites·9 claims
- 3287US9371517B2Modified forms of Pseudomonas exotoxin AINTREXON CORP·Filed 2014·Granted Jun 21, 2016·3 cites·23 claims
- 3387US9321841B2Humanised anti-CD52 antibodiesJONES TIMOTHY DAVID·Filed 2012·Granted Apr 26, 2016·11 cites·21 claims
- 3487US7465572B2De-immunized streptokinaseMERCK PATENT GMBH·Filed 2006·Granted Dec 16, 2008·4 cites·2 claims
- 3587US5874060ARecombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1997·Granted Feb 23, 1999·49 cites·7 claims
- 3687US2024150493A1Anti-kit antibodies and uses thereofCELLDEX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3786US11891452B2Anti-kit antibodies and uses thereofCELLDEX THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·1 cites·20 claims
- 3886US10259871B2Antibody specific for CD22 and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2015·Granted Apr 16, 2019·4 cites·30 claims
- 3986US7910104B2Modified anti-CD52 antibodyMERCK PATENT GMBH·Filed 2007·Granted Mar 22, 2011·6 cites·4 claims
- 4084US7381795B2Modified interferon beta with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Jun 3, 2008·9 cites·3 claims
- 4184US7264806B2Modified anti-CD52 antibodyBIOVATION LTD·Filed 2004·Granted Sep 4, 2007·15 cites·2 claims
- 4284US7087724B2Carrier moleculesAGEN BIOMEDICAL LTD·Filed 2002·Granted Aug 8, 2006·7 cites·8 claims
- 4383US7456257B2Fusion proteins of interferon alpha muteins with improved propertiesMERCK PATENT GMBH·Filed 2004·Granted Nov 25, 2008·20 cites·1 claims
- 4482US7931899B2Humanized anti-amyloid beta antibodiesMEDTRONIC INC·Filed 2008·Granted Apr 26, 2011·4 cites·17 claims
- 4581US7750136B2Modified bouganin proteins, cytotoxins and methods and uses thereofMERCK PATENT GMBH·Filed 2008·Granted Jul 6, 2010·4 cites·16 claims
- 4681US7615217B2Artificial proteins with reduced immunogenicityMERCK PATENT GMBH·Filed 2007·Granted Nov 10, 2009·3 cites·6 claims
- 4781US7524502B2Modified anti-TNF alpha antibodyMERCK PATENT GMBH·Filed 2002·Granted Apr 28, 2009·14 cites·4 claims
- 4881US6927025B1Methods for protein screeningBIOVATION LTD·Filed 2000·Granted Aug 9, 2005·21 cites·8 claims
- 4980US9988444B2Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicityPROCLARA BIOSCIENCES INC·Filed 2014·Granted Jun 5, 2018·4 cites·14 claims
- 5080US7754853B2TNF alpha-binding polypeptide compositions and methodsMERCK PATENT GMBH·Filed 2004·Granted Jul 13, 2010·11 cites·3 claims
Showing the top 50 of 138 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →